South Korea
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.38 B
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
2 |
USD 776.37 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
3 |
USD 715.16 M
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
4 |
USD 636.86 M
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
5 |
USD 527.70 M
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
6 |
USD 508.57 M
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
7 |
USD 433.54 M
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
8 |
USD 432.91 M
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
9 |
USD 372.20 M
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
10 |
USD 320.87 M
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
11 |
USD 311.07 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
12 |
USD 294.81 M
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
13 |
USD 287.90 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
14 |
USD 271.43 M
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
15 |
USD 257.80 M
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
16 |
USD 247.46 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
17 |
USD 236.83 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
18 |
USD 226.65 M
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
19 |
USD 203.60 M
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
20 |
USD 195.25 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
21 |
USD 157.58 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
22 |
USD 155.91 M
|
Dec. 31, 2023 | USD 11.53 | -7.22% |
|
South Korea |
|
23 |
USD 146.24 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
24 |
USD 138.30 M
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
25 |
USD 119.88 M
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
26 |
USD 116.25 M
|
Dec. 31, 2023 | USD 7.87 | -2.10% |
|
South Korea |
|
27 |
USD 112.04 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
28 |
USD 108.92 M
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
29 |
USD 102.81 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
30 |
USD 101.25 M
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
31 |
USD 94.04 M
|
Dec. 31, 2023 | USD 8.02 | 4.65% |
|
South Korea |
|
32 |
USD 91.94 M
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
33 |
USD 86.87 M
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
34 |
USD 84.23 M
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
35 |
USD 81.89 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
36 |
USD 75.36 M
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
37 |
USD 73.88 M
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
38 |
USD 73.23 M
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
39 |
USD 61.82 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
40 |
USD 61.65 M
|
Dec. 31, 2023 | USD 6.88 | -1.99% |
|
South Korea |
|
41 |
USD 59.69 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
42 |
USD 55.46 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
43 |
USD 55.39 M
|
Dec. 31, 2023 | USD 1.37 | -0.64% |
|
South Korea |
|
44 |
USD 51.63 M
|
Dec. 31, 2023 | USD 3.25 | -3.09% |
|
South Korea |
|
45 |
USD 50.30 M
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
46 |
USD 38.56 M
|
Dec. 31, 2023 | USD 1.89 | -1.74% |
|
South Korea |
|
47 |
USD 38.43 M
|
Dec. 31, 2023 | USD 3.10 | -3.13% |
|
South Korea |
|
48 |
USD 37.27 M
|
Dec. 31, 2023 | USD 3.01 | -3.95% |
|
South Korea |
|
49 |
USD 33.56 M
|
Dec. 31, 2023 | USD 1.18 | -3.42% |
|
South Korea |
|
50 |
USD 27.68 M
|
Dec. 31, 2023 | USD 9.81 | -0.42% |
|
South Korea |
The Healthcare company in South Korea with the highest Gross Profit is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 1.38 B.
The Healthcare company in South Korea with the lowest Gross Profit is GeneOne Life Science, Inc. (KSE: 011000.KS) at USD -11.51 M.
The top 10 Healthcare companies in South Korea by Gross Profit are Samsung Biologics Co.,Ltd., Celltrion, Inc., Daewoong Co., Ltd., Hanmi Pharm. Co., Ltd., Daewoong pharmaceutical Co.,Ltd, Chong Kun Dang Pharmaceutical Corp., Yuhan Corporation, Green Cross Holdings Corporation, Green Cross Corporation and Huons Global Co., Ltd..
The bottom 10 Healthcare companies in South Korea by Gross Profit are GeneOne Life Science, Inc., Aprogen pharmaceuticals,Inc., Sugentech Inc., EOFLOW Co.,Ltd., PCL, Inc., Cellid, Co., Ltd., MedPacto, Inc., HLB Life Science Co., Ltd., Genexine, Inc. and Peptron, Inc..